Dr Lal Path Labs Q4 Results: Co beats quarterly profit view on medical testing boom

April 25, 2025

Dr Lal Path Labs, India’s largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country.

More To Explore

Dalal Street Week Ahead: Sideways consolidation likely to persist amid global trade uncertainty

The Nifty experienced a week of range-bound trading, closing slightly lower with a 0.53% loss. Facing resistance near the upper edge of a rising channel,

July 26, 2025

Ashish Kacholia and Samara Capital backed Sahajanand Medical Technologies files DRHP for IPO

Sahajanand Medical Technologies (SMT) has filed for an IPO with SEBI to raise funds through an offer-for-sale of 27,644,231 equity shares. Prominent shareholders like Samara

July 26, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003